Open Access<p>Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis [Corrigendum]</p>
Author(s) -
Yosuke Kameoka,
Fukuko Kishi,
Minako Koura,
Yoshio Yamakawa,
Rora Nagasawa,
Fuyu Ito,
Junichiro Matsuda,
Osamu Suzuki,
Toshinori Nakayama,
Kazuo Suzuki
Publication year - 2019
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s212028
Subject(s) - recombinant dna , peripheral blood , medicine , drug , immunology , microbiology and biotechnology , vasculitis , chemistry , pharmacology , biology , biochemistry , gene , disease
Page 561, beginning at the left-hand bottom of the page, “The number of peripheral blood lymphocytes and granulocytes did not change in the aVAP2-administered mice: WBCs: 4.42 (1.36–7.57)×10 cells/L vs 3.14 (1.48–15.7)×10 cells/L (Figure S3A). The number of granulocytes decreased: 0.15 (0.05–1.04)×10 cells/L vs 0.22 (0.04–0.69)×10 cells/L (Figure S3B).” should instead read “The number of peripheral blood lymphocytes and granulocytes did not change in the aVAP2administered mice: WBCs: 2.11 (1.36–2.44)×10 cells/L vs 3.14 (1.48–15.7)×10 cells/L (Figure S3A). The number of granulocytes decreased: 0.055 (0.03–0.08)×10 cells/L vs 0.22 (0.04–0.69)×10 cells/L (Figure S3B).”
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom